Atosiban Acetate Injection - Global and China Top Players Market Share and Ranking 2023

Tables and Figures

Table 1. Atosiban Acetate Injection Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Atosiban Acetate Injection Market Restraints
Table 3. Atosiban Acetate Injection Market Trends
Table 4. Atosiban Acetate Injection Industry Policy
Table 5. Global Atosiban Acetate Injection Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Atosiban Acetate Injection Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Atosiban Acetate Injection Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Atosiban Acetate Injection Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Atosiban Acetate Injection Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Atosiban Acetate Injection Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Atosiban Acetate Injection Mergers & Acquisitions, Expansion Plans
Table 12. Global Atosiban Acetate Injection Manufacturers Product Type
Table 13. Head Office and Atosiban Acetate Injection Production Site of Key Manufacturer
Table 14. Atosiban Acetate Injection Capacity of Major Manufacturers and Future Plan
Table 15. China Atosiban Acetate Injection Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Atosiban Acetate Injection Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Atosiban Acetate Injection Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Atosiban Acetate Injection Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Atosiban Acetate Injection Production by Region, 2018-2023, (K Units)
Table 20. Global Atosiban Acetate Injection Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Atosiban Acetate Injection Upstream (Raw Materials)
Table 22. Global Atosiban Acetate Injection Typical Customers
Table 23. Atosiban Acetate Injection Typical Distributors
Table 24. By Type, Global Atosiban Acetate Injection Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Atosiban Acetate Injection Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Atosiban Acetate Injection Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Atosiban Acetate Injection Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Atosiban Acetate Injection Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Atosiban Acetate Injection Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Atosiban Acetate Injection Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Atosiban Acetate Injection Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Atosiban Acetate Injection Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Atosiban Acetate Injection Sales Quantity Market Share, 2018-2029
Table 34. Bachem Company Information, Head Office, Market Area, and Industry Position
Table 35. Bachem Atosiban Acetate Injection Models, Specifications, and Application
Table 36. Bachem Atosiban Acetate Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Bachem Company Profile and Main Business
Table 38. Bachem Recent Developments
Table 39. Piramal Pharma Solutions Company Information, Head Office, Market Area, and Industry Position
Table 40. Piramal Pharma Solutions Atosiban Acetate Injection Models, Specifications, and Application
Table 41. Piramal Pharma Solutions Atosiban Acetate Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Piramal Pharma Solutions Company Profile and Main Business
Table 43. Piramal Pharma Solutions Recent Developments
Table 44. Transo-Pharm Company Information, Head Office, Market Area, and Industry Position
Table 45. Transo-Pharm Atosiban Acetate Injection Models, Specifications, and Application
Table 46. Transo-Pharm Atosiban Acetate Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Transo-Pharm Company Profile and Main Business
Table 48. Transo-Pharm Recent Developments
Table 49. Rochem International Company Information, Head Office, Market Area, and Industry Position
Table 50. Rochem International Atosiban Acetate Injection Models, Specifications, and Application
Table 51. Rochem International Atosiban Acetate Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Rochem International Company Profile and Main Business
Table 53. Rochem International Recent Developments
Table 54. Suanfarma Company Information, Head Office, Market Area, and Industry Position
Table 55. Suanfarma Atosiban Acetate Injection Models, Specifications, and Application
Table 56. Suanfarma Atosiban Acetate Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Suanfarma Company Profile and Main Business
Table 58. Suanfarma Recent Developments
Table 59. Teva Pharmaceutical Industries Company Information, Head Office, Market Area, and Industry Position
Table 60. Teva Pharmaceutical Industries Atosiban Acetate Injection Models, Specifications, and Application
Table 61. Teva Pharmaceutical Industries Atosiban Acetate Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Teva Pharmaceutical Industries Company Profile and Main Business
Table 63. Teva Pharmaceutical Industries Recent Developments
Table 64. PolyPeptide Group Company Information, Head Office, Market Area, and Industry Position
Table 65. PolyPeptide Group Atosiban Acetate Injection Models, Specifications, and Application
Table 66. PolyPeptide Group Atosiban Acetate Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. PolyPeptide Group Company Profile and Main Business
Table 68. PolyPeptide Group Recent Developments
Table 69. Emcure Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 70. Emcure Pharmaceuticals Atosiban Acetate Injection Models, Specifications, and Application
Table 71. Emcure Pharmaceuticals Atosiban Acetate Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Emcure Pharmaceuticals Company Profile and Main Business
Table 73. Emcure Pharmaceuticals Recent Developments
Table 74. Smaart Pharmaceutticals Company Information, Head Office, Market Area, and Industry Position
Table 75. Smaart Pharmaceutticals Atosiban Acetate Injection Models, Specifications, and Application
Table 76. Smaart Pharmaceutticals Atosiban Acetate Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Smaart Pharmaceutticals Company Profile and Main Business
Table 78. Smaart Pharmaceutticals Recent Developments
Table 79. Omgene Life Sciences Company Information, Head Office, Market Area, and Industry Position
Table 80. Omgene Life Sciences Atosiban Acetate Injection Models, Specifications, and Application
Table 81. Omgene Life Sciences Atosiban Acetate Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Omgene Life Sciences Company Profile and Main Business
Table 83. Omgene Life Sciences Recent Developments
Table 84. BCN Peptides Company Information, Head Office, Market Area, and Industry Position
Table 85. BCN Peptides Atosiban Acetate Injection Models, Specifications, and Application
Table 86. BCN Peptides Atosiban Acetate Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. BCN Peptides Company Profile and Main Business
Table 88. BCN Peptides Recent Developments
Table 89. MSN Laboratories Company Information, Head Office, Market Area, and Industry Position
Table 90. MSN Laboratories Atosiban Acetate Injection Models, Specifications, and Application
Table 91. MSN Laboratories Atosiban Acetate Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. MSN Laboratories Company Profile and Main Business
Table 93. MSN Laboratories Recent Developments
Table 94. Carbosynth Company Information, Head Office, Market Area, and Industry Position
Table 95. Carbosynth Atosiban Acetate Injection Models, Specifications, and Application
Table 96. Carbosynth Atosiban Acetate Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Carbosynth Company Profile and Main Business
Table 98. Carbosynth Recent Developments
Table 99. Tecoland Company Information, Head Office, Market Area, and Industry Position
Table 100. Tecoland Atosiban Acetate Injection Models, Specifications, and Application
Table 101. Tecoland Atosiban Acetate Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Tecoland Company Profile and Main Business
Table 103. Tecoland Recent Developments
Table 104. Jigs Chemical Company Information, Head Office, Market Area, and Industry Position
Table 105. Jigs Chemical Atosiban Acetate Injection Models, Specifications, and Application
Table 106. Jigs Chemical Atosiban Acetate Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Jigs Chemical Company Profile and Main Business
Table 108. Jigs Chemical Recent Developments
Table 109. LGM Pharma Company Information, Head Office, Market Area, and Industry Position
Table 110. LGM Pharma Atosiban Acetate Injection Models, Specifications, and Application
Table 111. LGM Pharma Atosiban Acetate Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 112. LGM Pharma Company Profile and Main Business
Table 113. LGM Pharma Recent Developments
Table 114. Hangzhou Go Top Peptide Biotech Company Information, Head Office, Market Area, and Industry Position
Table 115. Hangzhou Go Top Peptide Biotech Atosiban Acetate Injection Models, Specifications, and Application
Table 116. Hangzhou Go Top Peptide Biotech Atosiban Acetate Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 117. Hangzhou Go Top Peptide Biotech Company Profile and Main Business
Table 118. Hangzhou Go Top Peptide Biotech Recent Developments
Table 119. Sun Pharmaceutical lndustrie Company Information, Head Office, Market Area, and Industry Position
Table 120. Sun Pharmaceutical lndustrie Atosiban Acetate Injection Models, Specifications, and Application
Table 121. Sun Pharmaceutical lndustrie Atosiban Acetate Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 122. Sun Pharmaceutical lndustrie Company Profile and Main Business
Table 123. Sun Pharmaceutical lndustrie Recent Developments
Table 124. Hainan Zhonghe Company Information, Head Office, Market Area, and Industry Position
Table 125. Hainan Zhonghe Atosiban Acetate Injection Models, Specifications, and Application
Table 126. Hainan Zhonghe Atosiban Acetate Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 127. Hainan Zhonghe Company Profile and Main Business
Table 128. Hainan Zhonghe Recent Developments
Table 129. Shanghai SOHO YIMING Company Information, Head Office, Market Area, and Industry Position
Table 130. Shanghai SOHO YIMING Atosiban Acetate Injection Models, Specifications, and Application
Table 131. Shanghai SOHO YIMING Atosiban Acetate Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 132. Shanghai SOHO YIMING Company Profile and Main Business
Table 133. Shanghai SOHO YIMING Recent Developments
Table 134. Hybio Pharmaceutical Atosiban Acetate Injection Company Information, Head Office, Market Area, and Industry Position
Table 135. Hybio Pharmaceutical Atosiban Acetate Injection Models, Specifications, and Application
Table 136. Hybio Pharmaceutical Atosiban Acetate Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 137. Hybio Pharmaceutical Company Profile and Main Business
Table 138. Hybio Pharmaceutical Recent Developments
Table 139. Hainan Herui Company Information, Head Office, Market Area, and Industry Position
Table 140. Hainan Herui Atosiban Acetate Injection Models, Specifications, and Application
Table 141. Hainan Herui Atosiban Acetate Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 142. Hainan Herui Company Profile and Main Business
Table 143. Hainan Herui Recent Developments
Table 144. Chengdu Shengnuo Company Information, Head Office, Market Area, and Industry Position
Table 145. Chengdu Shengnuo Atosiban Acetate Injection Models, Specifications, and Application
Table 146. Chengdu Shengnuo Atosiban Acetate Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 147. Chengdu Shengnuo Company Profile and Main Business
Table 148. Chengdu Shengnuo Recent Developments
List of Figures
Figure 1. Atosiban Acetate Injection Picture
Figure 2. Global Atosiban Acetate Injection Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Atosiban Acetate Injection Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Atosiban Acetate Injection Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Atosiban Acetate Injection Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Atosiban Acetate Injection Sales Quantity (K Units) & (2018-2029)
Figure 7. China Atosiban Acetate Injection Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Atosiban Acetate Injection Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Atosiban Acetate Injection Market Share of Global, 2018-2029
Figure 10. Global Atosiban Acetate Injection Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Atosiban Acetate Injection Key Participants, Market Share, 2022
Figure 12. Global Atosiban Acetate Injection Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Atosiban Acetate Injection Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Atosiban Acetate Injection Production Market Share & Forecast by Region, 2018-2029
Figure 15. Atosiban Acetate Injection Industry Chain
Figure 16. Atosiban Acetate Injection Procurement Model
Figure 17. Atosiban Acetate Injection Sales Model
Figure 18. Atosiban Acetate Injection Sales Channels, Direct Sales, and Distribution
Figure 19. 0.9 ml
Figure 20. 5 ml
Figure 21. By Type, Global Atosiban Acetate Injection Consumption Value, 2018-2029, US$ Million
Figure 22. By Type, Global Atosiban Acetate Injection Consumption Value Market Share, 2018-2029
Figure 23. By Type, Global Atosiban Acetate Injection Sales Quantity, 2018-2029, (K Units)
Figure 24. By Type, Global Atosiban Acetate Injection Sales Quantity Market Share, 2018-2029
Figure 25. By Type, Global Atosiban Acetate Injection Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 26. Threatened Preterm Birth
Figure 27. Inhibits Lactation
Figure 28. Others
Figure 29. By Application, Global Atosiban Acetate Injection Consumption Value, 2018-2029, US$ Million
Figure 30. By Application, Global Atosiban Acetate Injection Consumption Value Market Share, 2018-2029
Figure 31. By Application, Global Atosiban Acetate Injection Sales Quantity, 2018-2029, (K Units)
Figure 32. By Application, Global Atosiban Acetate Injection Sales Quantity Market Share, 2018-2029
Figure 33. By Application, Global Atosiban Acetate Injection Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 34. By Region, Global Atosiban Acetate Injection Consumption Value Market Share, 2018-2029
Figure 35. By Region, Global Atosiban Acetate Injection Sales Quantity Market Share, 2018-2029
Figure 36. North America Atosiban Acetate Injection Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 37. By Country, North America Atosiban Acetate Injection Consumption Value Market Share, 2022
Figure 38. Europe Atosiban Acetate Injection Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 39. By Country, Europe Atosiban Acetate Injection Consumption Value Market Share, 2022
Figure 40. Asia Pacific Atosiban Acetate Injection Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 41. By Country/Region, Asia Pacific Atosiban Acetate Injection Consumption Value Market Share, 2022
Figure 42. South America Atosiban Acetate Injection Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 43. By Country, South America Atosiban Acetate Injection Consumption Value Market Share, 2022
Figure 44. Middle East & Africa Atosiban Acetate Injection Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 45. U.S. Atosiban Acetate Injection Sales Quantity, 2018-2029, (K Units)
Figure 46. By Type, U.S. Atosiban Acetate Injection Sales Quantity Market Share, 2022 VS 2029
Figure 47. By Application, U.S. Atosiban Acetate Injection Sales Quantity Market Share, 2022 VS 2029
Figure 48. Europe Atosiban Acetate Injection Sales Quantity, 2018-2029, (K Units)
Figure 49. By Type, Europe Atosiban Acetate Injection Sales Quantity Market Share, 2022 VS 2029
Figure 50. By Application, Europe Atosiban Acetate Injection Sales Quantity Market Share, 2022 VS 2029
Figure 51. China Atosiban Acetate Injection Sales Quantity, 2018-2029, (K Units)
Figure 52. By Type, China Atosiban Acetate Injection Sales Quantity Market Share, 2022 VS 2029
Figure 53. By Application, China Atosiban Acetate Injection Sales Quantity Market Share, 2022 VS 2029
Figure 54. Japan Atosiban Acetate Injection Sales Quantity, 2018-2029, (K Units)
Figure 55. By Type, Japan Atosiban Acetate Injection Sales Quantity Market Share, 2022 VS 2029
Figure 56. By Application, Japan Atosiban Acetate Injection Sales Quantity Market Share, 2022 VS 2029
Figure 57. South Korea Atosiban Acetate Injection Sales Quantity, 2018-2029, (K Units)
Figure 58. By Type, South Korea Atosiban Acetate Injection Sales Quantity Market Share, 2022 VS 2029
Figure 59. By Application, South Korea Atosiban Acetate Injection Sales Quantity Market Share, 2022 VS 2029
Figure 60. Southeast Asia Atosiban Acetate Injection Sales Quantity, 2018-2029, (K Units)
Figure 61. By Type, Southeast Asia Atosiban Acetate Injection Sales Quantity Market Share, 2022 VS 2029
Figure 62. By Application, Southeast Asia Atosiban Acetate Injection Sales Quantity Market Share, 2022 VS 2029
Figure 63. India Atosiban Acetate Injection Sales Quantity, 2018-2029, (K Units)
Figure 64. By Type, India Atosiban Acetate Injection Sales Quantity Market Share, 2022 VS 2029
Figure 65. By Application, India Atosiban Acetate Injection Sales Quantity Market Share, 2022 VS 2029
Figure 66. Middle East & Africa Atosiban Acetate Injection Sales Quantity, 2018-2029, (K Units)
Figure 67. By Type, Middle East & Africa Atosiban Acetate Injection Sales Quantity Market Share, 2022 VS 2029
Figure 68. By Application, Middle East & Africa Atosiban Acetate Injection Sales Quantity Market Share, 2022 VS 2029
Figure 69. Research Methodology
Figure 70. Breakdown of Primary Interviews
Figure 71. Bottom-up and Top-down Approaches
Figure 72. Top-down Approaches

Reason to Buy

• Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
• Highlights key business priorities in order to assist companies to realign their business strategies
• The segment that is expected to dominate the Pharma & Healthcare Market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets